Company Presentation from ONO Announcing the 1st Ono Golden Ticket Event
Company Presentation from ONO Announcing the 1st Ono Golden Ticket Event
MBC BioLabs & Ono Pharmaceutical Co., Ltd. Present the 2021 Golden Ticket Program
MBC BioLabs & Ono Pharmaceutical Co., Ltd. Present the 2021 Golden Ticket Program
Continuing our new lecture series in partnership with Y Combinator, we're excited to bring you Dr. Trevor Martin, CEO and Co-founder of Mammoth Biosciences. His team is doing fascinating work on new CRISPR applications. Join Zoom WebinarOur Speaker: Trevor Martin, PhD Dr. Trevor Martin founded Mammoth Biosciences with the mission to enable the next generation of CRISPR-based synthetic biology products across therapeutics and diagnostics, including a novel class of affordable, effective, and rapid CRISPR-enabled molecular diagnostics that allow individuals worldwide to better understand their health and a novel family of CRISPR Cas14 proteins that can enable in-vivo editing. Trevor earned his BA from Princeton University and his PhD in Biology from Stanford. His work has been featured in outlets including FiveThirtyEight and The Atlantic. He is the featured healthcare honoree on the Forbes 30 Under 30 list, is on Fortune’s 40 Under 40 list, and is a Malaria No More “10 to END” innovator.